Glyburide, a NLRP3 inhibitor, decreases inflammatory response and is a candidate to reduce pathology in Leishmania braziliensis infection

dc.creatorCarvalho, Augusto M.
dc.creatorNovais, Fernanda Oliveira
dc.creatorPaixão, Camilla S.
dc.creatorOliveira, Camila Indiani de
dc.creatorMachado, Paulo Roberto Lima
dc.creatorCarvalho, Lucas Pedreira de
dc.creatorScott, Phillip
dc.creatorCarvalho, Edgar Marcelino de
dc.date.accessioned2019-08-23T13:03:34Z
dc.date.accessioned2023-09-05T12:02:59Z
dc.date.available2019-08-23T13:03:34Z
dc.date.available2023-09-05T12:02:59Z
dc.date.created2019-08-23T13:03:34Z
dc.date.issued2019
dc.identifierCARVALHO, Augusto M. et al. Glyburide, a NLRP3 inhibitor, decreases inflammatory response and is a candidate to reduce pathology in Leishmania braziliensis infection. Journal of Investigative Dermatology, p. 1-17, May, 2019.
dc.identifier0022-202X
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/35011
dc.identifier10.1016/j.jid.2019.05.025
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8648171
dc.languageeng
dc.publisherElsevier
dc.rightsopen access
dc.titleGlyburide, a NLRP3 inhibitor, decreases inflammatory response and is a candidate to reduce pathology in Leishmania braziliensis infection
dc.typePreprint


Este ítem pertenece a la siguiente institución